Special Issue "Viruses and Cancer: From Cellular Mechanism to Therapeutic Aspects"
Deadline for manuscript submissions: closed (1 December 2023) | Viewed by 1763
Interests: merkel cell polyomavirus; merkel cell carcinoma; oncogenic viruses; immune evasion; DNA replication; virus latency; ubiquitin-protein ligases; oncogene; protein degradation; p53; cell cycle
Interests: human gammaherpesvirus 8; oncogenic viruses; t-lymphocytes; interferon regulatory factors; mitophagy; autophagy; apoptosis; NF-kB; ubiquitination; cytokines; virus-host interactions
Viruses cause a wide spectrum of clinical diseases; several have even been shown to be capable of causing cancers in humans. Additional events and host factors, such as an immunosuppressive tumor microenvironment, oncogenic mutations accumulated with age, and host genetic predisposition, are also predicted to play a role in viral diseases. A comprehensive understanding of viral oncogenesis and the molecular mechanisms of host responses may enable the identification of unknown infectious cancer etiologies; thus, enhancing our knowledge of this area holds much promise for the development of more effective and tolerable strategies for virus-associated cancers.
This Special Issue of Cells aims to bring together the latest key findings on host responses during virus infection leading to viral oncogenesis and discuss new diagnostic and therapeutic ideas and applications. Research areas of interest include (but are not limited to) the following topics:
- Host cell responses: cellular and molecular mechanisms;
- Virus–host interaction;
- Host immunity and viral evasion mechanisms;
- Viral oncogenesis;
- Metabolic reprogramming;
- Therapeutic approaches.
Original research articles and reviews are both welcome. We look forward to receiving your contributions.
Dr. Hyun Jin Kwun
Dr. Young Bong Choi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- virus-induced cancer
- host stress responses
- DNA damage response
- virus–host interactions
- cellular innate immunity
- cell metabolism
- immune evasion mechanisms
- therapeutic approach